← Back to guidelines
Gastroenterology16 papers

Hepatic ascites

Last edited: 4/10/2026

Overview

Hepatic ascites is the accumulation of excess fluid in the peritoneal cavity due to portal hypertension, most commonly caused by cirrhosis 1. It is a common complication of advanced liver disease and is associated with significant morbidity and mortality 1.

Diagnosis

  • Diagnosis is primarily clinical, based on physical examination findings (e.g., shifting dullness, fluid wave) and confirmed by abdominal ultrasound 1.
  • Diagnostic paracentesis is recommended for all patients with new-onset ascites to rule out spontaneous bacterial peritonitis (SBP) 1.
  • Ascitic fluid analysis includes cell count with differential, total protein, albumin, and Gram stain 1.
  • Serum-ascites albumin gradient (SAAG) is a key diagnostic marker; SAAG ≥ 1.1 g/dL suggests portal hypertension 1.
  • Management

  • First-line treatment:
  • * Sodium restriction (< 2 grams/day) 1. * Diuretic therapy with spironolactone and furosemide 1. Doses should be carefully titrated based on urine sodium excretion and potassium levels 1.
  • Therapeutic paracentesis:
  • * Indicated for rapid, symptomatic relief of tense ascites 1. * Large-volume paracentesis (> 5 liters) should be accompanied by intravenous albumin infusion (e.g., 6-8 g/L of ascites removed) to prevent circulatory dysfunction 1.
  • Adjunctive treatments:
  • * TIPS (transjugular intrahepatic portosystemic stent shunt) may be considered for refractory ascites 1. * Antibiotic prophylaxis for SBP is recommended in patients with low ascitic fluid protein (< 1.5 g/dL) and impaired renal function or high bilirubin 1.

    Key Recommendations

  • Sodium restriction to < 2 grams/day is a cornerstone of ascites management 1. (Evidence: Strong)
  • Diuretic therapy with spironolactone and furosemide is the first-line pharmacological treatment for ascites 1. (Evidence: Strong)
  • Therapeutic paracentesis with concurrent albumin infusion is recommended for patients with tense ascites requiring rapid symptom relief 1. (Evidence: Strong)
  • References

    1 Aithal GP, Palaniyappan N, China L, Härmälä S, Macken L, Ryan JM et al.. Guidelines on the management of ascites in cirrhosis. Gut 2021. link

    Original source

    1. [1]
      Guidelines on the management of ascites in cirrhosis.Aithal GP, Palaniyappan N, China L, Härmälä S, Macken L, Ryan JM et al. Gut (2021)
    2. [2]
      Strategies for intractable ascites after hepatic resection: analysis of two cases.Maeda T, Shimada M, Shirabe K, Taketomi A, Matsumata T, Sugimachi K The British journal of clinical practice (1995)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG